Reported Q: Q4 2024 Rev YoY: +3.5% EPS YoY: +22.2% Move: -0.68%
Church Dwight Co Inc
0R13.L
$99.10 -0.68%
Exchange LSE Sector Consumer Defensive Industry Household Personal Products
Q4 2024
Published: Feb 13, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0R13.L

Reported

Report Date

Feb 13, 2025

Quarter Q4 2024

Revenue

1.58B

YoY: +3.5%

EPS

0.76

YoY: +22.2%

Market Move

-0.68%

Previous quarter: Q3 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $1.58B up 3.5% year-over-year
  • EPS of $0.76 increased by 22.2% from previous year
  • Gross margin of 44.7%
  • Net income of 189.20M
  • "" -
0R13.L
Company 0R13.L

Executive Summary

Church & Dwight reported a solid Q4 2024, delivering revenue of $1.582 billion, up 3.5% year over year and 4.7% quarter over quarter. The quarter produced a meaningful margin recovery with gross profit of $707.9 million and a gross margin of approximately 44.7%, contributing to an operating income of $256.7 million and an operating margin around 16.2%. Net income reached $189.2 million, with diluted earnings per share of $0.76–$0.77, marking a strong post-Q3 rebound after a negative operating result in Q3 2024. Free cash flow generation remained robust, with cash from operations of $292.3 million and free cash flow of $237.7 million, supporting a solid balance sheet and a dividend policy reflected in a payout ratio near 36.8%. The earnings trajectory underscores CHD’s resilient consumer staples position, diversified product portfolio, and ability to translate topline growth into meaningful profitability and cash generation despite industry headwinds.

Key drivers included a favorable mix and pricing resilience across core brands (ARM & HAMMER, OXICLEAN, XTRA, FIRST RESPONSE and other flagship lines), improving operating leverage, and disciplined working capital management. The balance sheet shows ample liquidity (cash of $964.1 million) and a net debt position of about $1.44 billion, with interest coverage demonstrating cushion (about 11x). Valuation remains elevated versus broad market benchmarks, reflecting CHD’s defensible brand moat and steady cash flow generation. Investors should monitor input costs (raw materials, packaging), channel mix shifts, and currency dynamics given the London Stock Exchange listing (0R13.L) in USD terms, as well as any potential shifts in keep-through demand for household and personal care products.

Key Performance Indicators

Revenue
Increasing
1.58B
QoQ: 4.73% | YoY: 3.53%
Gross Profit
Increasing
707.90M
44.75% margin
QoQ: 3.63% | YoY: 8.86%
Operating Income
Increasing
256.70M
QoQ: 380.55% | YoY: 18.79%
Net Income
Increasing
189.20M
QoQ: 351.93% | YoY: 23.10%
EPS
Increasing
0.77
QoQ: 348.39% | YoY: 22.22%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 1,585.60 0.74 +5.0% View
Q2 2025 1,506.30 0.78 -0.3% View
Q1 2025 1,467.10 0.89 -2.4% View
Q4 2024 1,582.00 0.76 +3.5% View
Q3 2024 1,510.60 -0.31 +3.8% View